06 September 2023 | Wednesday | News
Image Source | Public Domain
Baird Medical's MWA products have been available in China for many years, and the Company is known as a market leader in MWA technology for thyroid and breast nodules. This technology offers minimally invasive treatment methods, providing both precision and reduced complications while improving the overall patient experience.
Ms. Haimei Wu, Founder and CEO of Baird Medical, said, "Securing approval for our SSBN technology both strengthens our company's pipeline and provides medical personnel with biopsy products that complement MWA procedures."
© 2024 Biopharma Boardroom. All Rights Reserved.